Animal Health Active Pharmaceutical Ingredients Market Trends and Demand 2017-2025
Animal Health Active Pharmaceutical Ingredients Market | According to a recent study by Persistence Market Research (PMR). PMR’s study estimates the market to increase from revenues worth US$ 5,216.1 Mn in 2017 to reach US$ 9,162.2 Mn by 2025-end.
Animal Health Active Pharmaceutical Ingredients Market | According to a recent study by Persistence Market Research (PMR). PMR’s study estimates the market to increase from revenues worth US$ 5,216.1 Mn in 2017 to reach US$ 9,162.2 Mn by 2025-end.
- TAGS
- animal-health-api
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Global <strong>Market</strong> Study<br />
on <strong>Animal</strong> <strong>Health</strong><br />
<strong>Active</strong><br />
<strong>Pharmaceutical</strong> <strong>Ingredients</strong>: Antiparasitics Segment by API Type to<br />
Register a CAGR of 7.6% During <strong>2017</strong>-<strong>2025</strong><br />
The global animal health active pharmaceutical ingredient (API) market is<br />
expected to register an impressive expansion at 7.3% CAGR during the forecast<br />
period <strong>2017</strong>-<strong>2025</strong>. According to recent study by Persistence <strong>Market</strong> Research<br />
(PMR), it is estimated that, the revenues from animal health API market are<br />
expected to reach worth US$ 9,162.2 Mn by <strong>2025</strong>-end.<br />
Limited Government Intervention Provides Smooth Flow to the <strong>Market</strong><br />
Growth in APAC<br />
Asia-Pacific (APAC) will be the most lucrative region in the global animal<br />
health active pharmaceutical market, <strong>and</strong> is expected to exhibit higher CAGR<br />
by <strong>2025</strong>-end. APAC region has been identified for housing some of the largest<br />
suppliers of affordable API. To save on the production costs, the concerned<br />
governments have been taking initiatives to compel small scale API<br />
manufacturers towards shifting their production units to APAC countries such<br />
as India <strong>and</strong> China. Limited intervention of government facilitates smoother<br />
flow of market growth in these countries.<br />
However, according to western health regulatory agencies, API imported by<br />
APAC manufactures doesn’t meet the required specification criteria set by ICH<br />
(International Conference on Harmonization). There are concerns related to the<br />
quality, safety <strong>and</strong> efficacy of such APIs.<br />
Browse Full Research Report:<br />
https://www.persistencemarketresearch.com/market-research/animal-healthactive-pharmaceutical-ingredients-market.asp
Western regulatory agencies are taking stringent actions on the APIs produced<br />
in these region. The companies engaged in production are facing challenges<br />
while bridging the gap between cost <strong>and</strong> the quality of APIs. Strict validations<br />
<strong>and</strong> guidelines set by regulatory agencies are expected to hamper the growth of<br />
API market in APAC region.<br />
Europe to Remain the Second Largest <strong>Market</strong> for <strong>Animal</strong> <strong>Health</strong> APIs<br />
Europe is expected to remain the second largest market for animal health active<br />
pharmaceutical ingredients. Most of the leading healthcare companies operating<br />
through Europe continuously require bulk amount of animal grade APIs. In<br />
addition, consumption of animal grade API has increased substantially over the<br />
past few years. Spain is one of the largest consumer of animal-grade<br />
antimicrobial APIs in Europe.<br />
APIs can facilitate productivity enhancement, which is of significant value to<br />
the animal healthcare industry. Such factors are expected to augment the growth<br />
of animal health API market in EU. Stringent approval process implemented by<br />
the European Medicinal Agency (EMA) only permits registered APIs for their<br />
use in production of pharmaceuticals. This is likely to result shortage of<br />
intermediates <strong>and</strong> materials. The stringent guidelines as well as fragmented<br />
market are likely to curb the market growth of animal grade API in Europe.<br />
Request <strong>and</strong> Download Sample Report@<br />
https://www.persistencemarketresearch.com/samples/16972<br />
Antiparasitics to Remain in Large Dem<strong>and</strong> in the <strong>Market</strong><br />
• Anti-parasitics expected to be the largely adopted active pharmaceutical<br />
ingredient in the market<br />
• Frequent bacterial infection to pets dem<strong>and</strong>s Anti-infective, which in turn<br />
projected to account for the largest revenue by <strong>2025</strong>-end<br />
• Revenues from the sale of anesthetics <strong>and</strong> NSIDs will remain same as<br />
compared to the collective revenues of anti-parasitics <strong>and</strong> anti-infectives<br />
Key market players profiled in PMR’s report include Glenmark <strong>Pharmaceutical</strong><br />
Limited., Zoetis, Inc., Eli Lilly & Co., Sanofi Winthrop Industrie (CEPiA),<br />
Indukern, S.A., Ofichem BV, P&R S.p.A (Olon S.p.A), Lonza Group AG,<br />
Huvepharma AD, Ourofino Saude <strong>Animal</strong>, Blanver Farmoquimica E<br />
Farmaceutica S.A., Zhejiang Hisun <strong>Pharmaceutical</strong> Co., Ltd, Changzhou<br />
Yabang-Qh Pharmachem Co., Ltd., Shanghai Pharmtech Co., Ltd., Ningxia
Tairui <strong>Pharmaceutical</strong> Co., Ltd., Shaanxi Hanjiang <strong>Pharmaceutical</strong> Group Co.,<br />
Ltd., Sequent Scientific Ltd., NGL Fine-Chem Ltd., Omkar Speciality<br />
Chemicals Ltd., <strong>and</strong> Excel Industries Ltd.<br />
Buy Full Eye <strong>Animal</strong> <strong>Health</strong> <strong>Active</strong> <strong>Pharmaceutical</strong> <strong>Ingredients</strong> <strong>Market</strong><br />
Report<br />
@ https://www.persistencemarketresearch.com/checkout/16972<br />
About Us<br />
Persistence <strong>Market</strong> Research (PMR) is a third-platform research firm. Our<br />
research model is a unique collaboration of data analytics <strong>and</strong> market research<br />
methodology to help businesses achieve optimal performance.<br />
To support companies in overcoming complex business challenges, we follow a<br />
multi-disciplinary approach. At PMR, we unite various data streams from<br />
multi-dimensional sources. By deploying real-time data collection, big data, <strong>and</strong><br />
customer experience analytics, we deliver business intelligence for<br />
organizations of all sizes.<br />
Contact Us<br />
Persistence <strong>Market</strong> Research<br />
305 Broadway<br />
7th Floor, New York City,<br />
NY 10007, United States,<br />
USA – Canada Toll Free: 800-961-0353<br />
Email: sales@persistencemarketresearch.com<br />
Web: http://www.persistencemarketresearch.com